Table 2.
Admission course and treatment.
| N (%) or Mean ± SD | |||||
|---|---|---|---|---|---|
| Total (N = 233) | Confirmed COPD (N = 104) | No COPD (N = 53) | Never had Spirometry (N = 76) | p-Value | |
| Antibiotics | 183 | 88 | 39 | 56 | 0.13 |
| (78.5) | (84.6) | (73.6) | (73.7) | ||
| Bronchodilators (Short acting) | 208 | 94 | 47 | 67 | 0.89 |
| (89.3) | (90.4) | (88.7) | (88.2) | ||
| Systemic steroids | 186 | 86 | 42 | 58 | 0.57 |
| (79.8) | (82.7) | (79.2) | (76.3) | ||
| Heart failure therapy | 39 (16.7) | 16 (15.4) | 8 (15.1) | 15 (19.7) | 0.25 |
| Respiratory support | 45 (19.4) | 27 (26) | 6 (11.5) | 12 (15.8) | 0.06 |
| Pulmonologist consultation during admission | 42 | 26 | 9 | 7 | 0.02 |
| (18.0) | (25.0) | (17.0) | (9.2) | ||
| Pulmonologist consultation following admission | 118 | 81 | 29 | 8 | <0.01 |
| (50.6) | (77.9) | (54.7) | (10.5) | ||
| COPD diagnosis remained after admission | 229 | 104 | 51 | 74 | 0.17 |
| (98.3) | (100.0) | (96.2) | (97.4) | ||
| Laboratory results | |||||
| WBC | 11.4 ± 7 | 12.3 ± 5.6 | 10.6 ± 11 | 10.7 ± 4.6 | <0.01 |
| CRP | 6.1 ± 9 | 6.5 ± 9 | 4.8 ± 7.8 | 6.4 ± 10.3 | 0.75 |
| PCO2 | 49.7 ± 15.2 | 53 ± 16 | 44.5 ± 13.8 | 48.4 ± 14 | <0.01 |
Admission course and treatment in the patient groups. F/U = follow up; Respiratory support = invasive or non-invasive mechanical ventilation; WBC = White blood cell count; PCO2 = partial pressure of carbon dioxide; CRP = C-reactive protein; p < 0.0045 considered to be significant.